Atlas FDA

CINtec PLUS Cytology

FDA premarket approval P190024/S001 · decided 2020-08-14

Approval details

PMA number
P190024
Supplement
S001
Supplement type
Normal 180 Day Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
CINtec PLUS Cytology
Generic name
Immunocytochemistry assay, p16/Ki-67
Applicant
Ventana Medical Systems, Inc.
Date received
2020-04-28
Decision date
2020-08-14
Days to decision
108 days
Decision code
APPR
Product code
QKF
Advisory committee
Pathology
Expedited review
No
Location
Tucson, AZ
Statement
Approval for expanding the indications for use to add the cobas® 6800/8800 Systems (cobas® HPV) test to identify HPV positive patients.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Roche Digital Pathology Dx (K242783)Ventana Medical Systems, Inc.2024-12-17
VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail (08507023001) (DEN240025)Ventana Medical Systems, Inc.2024-12-05
Roche Digital Pathology Dx (VENTANA DP 200) (K232879)Ventana Medical Systems, Inc.2024-06-14
CINtec Histology (K212176)Ventana Medical Systems, Inc.2021-12-10
VENTANA CD30 (Ber-H2) RxDx Assay (K172471)Ventana Medical Systems, Inc.2018-05-08
CINtec Histology (50 tests), CINtec Histology (250 tests) (DEN160019)Ventana Medical Systems, Inc.2017-03-04
Virtuoso System for IHC PR (1E2) using iScan HT (K142965)Ventana Medical Systems, Inc.2015-07-16
VIRTUOSO SYSTEM FOR IHC ER (SP1) WITH BENCHMARK ULTRA STAINER (K140465)Ventana Medical Systems, Inc.2014-03-20